Defective HIV copies explain most persistent traces in blood following treatment, study finds

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However ...
News-Medical.Net

Defective HIV copies explain persistent viral traces during treatment

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives.

‘One step closer’ to HIV cure as new treatment ends the need for daily pill

A BREAKTHROUGH discovery could see HIV patients be drug-free for up to two years, removing the need for daily pills, a trial has suggested. The trial, led by Imperial College London, found ...

New HIV treatment could allow patients to go drug-free for two years

A quarter of people who took the new antibody mix were able to go two years without taking a daily antiviral pill ...

Scientists discover how some people control HIV without daily medication

For decades, HIV treatment has depended on one hard truth: once medication stops, the virus usually comes roaring back.

New HIV infections, AIDS deaths hit 30-yr low, but world remains off track: Reports

UNAIDS report warns funding pressures threaten HIV gains, while highlighting support from India and China as the world ...

New Long Acting Oral HIV Regimen Meets Primary Endpoints In Phase 3 Trials

The combination of islatravir and lenacapavir targets multiple stages of HIV-1 replication, potentially offering people with ...
GlobalData on MSN

Gilead and MSD’s once-weekly HIV pill meets primary endpoints in Phase III trials

Gilead and MSD will be filing the data from the Phase III trials of the once-weekly HIV pill to regulatory authorities.

HIV enters the brain and doesn’t leave – paradoxically, drugs intended to reduce brain inflammation increase virus levels

HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave. HIV ...